ARCHIVES

Cancer Leadership Council letter calls for permanent leadership of NCI and FDA.

This article is from The Cancer Letter archive.

Vol. 31 No. 43 | November 23, 2005

Download PDF Visit The Full Archive

Related Articles

FDA Approves Rituxan For NHL With CHOP Therapy

February 24, 2006

Low Percentage Of Trials Published In Medical Journals

October 31, 2008

In Brief: New Clinical Oncology RFP Ready Soon; CCIRC, Joftes Agree On Funding Method For Symposia

March 9, 1979

Some NCI Responses To CCOP Letters Of Intent Missing; NCAB Debates Pediatric Issues

October 8, 1982

Risk of Lymphoma Increases with Hepatitis C Virus Infection

May 25, 2007

President’s Surgery Stirs Interest In Colon Cancer Exams

July 26, 1985